Evidence guides
Look beyond the headline.
Read what compounding records, offer terms, adverse-event reports and trial designs establish—and which conclusions remain unsupported.
Guide
Compounded tirzepatide: which record answers which question?
A company description, a pharmacy license and an individual medicine label establish different facts. Read them without filling in the gaps.
Guide
Two tirzepatide price records, and the separate semaglutide offer
Read CoreAge’s $199 product page and qualified $129 offer without confusing the separate $79 semaglutide card with a third tirzepatide price.
Guide
What a tirzepatide adverse-event report can—and cannot—tell you
Read the reporting period, product identity and missing information before interpreting a safety total.
Guide
A tirzepatide trial regimen is more than an ingredient name
SURMOUNT-4 shows why the treatment period, participant selection and randomized question must stay attached to a result.